Abstract

T1D is an incurable, life-limiting disease. Dependence on exogenous insulin for glycemic control has several challenges, including impaired awareness of hypoglycemia (IAH) and severe hypoglycemic events (SHE). There is limited understanding of the impact these serious and acute conditions have on productivity and out-of-pocket (OOP) costs of adult continuous glucose monitor (CGM) users. This research aims to describe this impact.